Next Quarterly Earnings
Thursday, July 30, 2026
CW 31
After-Hours
In 25 days
Ultragenyx Pharmaceutical is a US-based biopharmaceutical company dedicated to the development and commercialization of transformative medicines for rare and ultra-rare genetic diseases. The company focuses on innovative therapeutic approaches, including gene therapies and other novel biologics, to offer patients worldwide new treatment options and improved quality of life.